cas 2101236-46-6|| where to buy 2-acetyl-N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-5-(methylsulfonyl)-2,3-dihydro-1H-isoindole-1-carboxamide

Nombre del producto:2-acetyl-N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-5-(methylsulfonyl)-2,3-dihydro-1H-isoindole-1-carboxamide

IUPAC Name:2-acetyl-N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-5-methanesulfonyl-2,3-dihydro-1H-isoindole-1-carboxamide

: CAS：2101236-46-6; Fórmula molecular：C21H18F6N2O5S; Pureza：95%+

Unidad de embalaje	Stock disponible	Precio($)	Cantidad

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2101236-46-6 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :2101236-46-6; Fórmula molecular:C21H18F6N2O5S; Punto de fusión:-; Código de sonrisas:CC(=O)N1CC2=CC(=CC=C2C1C(=O)NC1=CC=C(C=C1)C(O)(C(F)(F)F)C(F)(F)F)S(C)(=O)=O; Densidad:

: Número de catálogo:CM1000211; Peso molecular:524.43; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Fluorinated Compounds; Fluorine is the most electronegative element in the periodic table, and the fluorine atom has a small atomic radius, so fluorine-containing organic compounds have many wonderful properties. For example, the introduction of fluorine atoms or fluorine-containing groups into drug molecules can improve the permeability to cell membranes, metabolic stability and bioavailability; in addition, the introduction of fluorine atoms will improve the lipid solubility of the compound and promote its absorption in the body. The speed of delivery changes the physiological effect. In the field of medicinal chemistry, the introduction of fluorine atoms into organic molecules is an important direction for the development of new anticancer drugs, antitumor drugs, antiviral agents, anti-inflammatory drugs, and central nervous system drugs.